Biomark Capital Management Co. LLC
data from 30/09/2018
Capitalization
Portfolio size
Portfolio performance
Portfolio performance %
Performance compared to S&P 500 (%)
Stock in Biomark Capital Management Co. LLC
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2018/09/30 | ADMA | ADMA BIOLOGICS, INC. | 99.96% | 8.901 M $ | 1433304 | 2015/12/31 | 1.921 M $ | 29.71 % |
| 2018/09/30 | MABVAX THERAPEUTICS HOLDINGS, INC. | 0.04% | 4.000 K $ | 8903 | 2018/03/31 | -3.999 K $ | -50.00 % |